-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sparsentan in Focal Segmental Glomerulosclerosis (FSGS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sparsentan in Focal Segmental Glomerulosclerosis (FSGS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sparsentan in Focal Segmental Glomerulosclerosis (FSGS) Drug Details: Sparsentan...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VB-119 in Focal Segmental Glomerulosclerosis (FSGS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VB-119 in Focal Segmental Glomerulosclerosis (FSGS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VB-119 in Focal Segmental Glomerulosclerosis (FSGS) Drug Details: VB-119 is...
-
Product Insights
Focal Segmental Glomerulosclerosis (FSGS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Focal Segmental Glomerulosclerosis (FSGS) - Drugs In Development, 2023’, provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Focal Segmental Glomerulosclerosis (FSGS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval Analysis for Partial Seizure
Overview How likely is it that the drugs in Partial Seizure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Partial Seizure Overview Focal onset seizures, or partial seizures, are prevalent neurological...
-
Product Insights
MPPMCL Focal Energy Solar PV Park
MPPMCL Focal Energy Solar PV Park is a solar PV project located in Madhya Pradesh, India. The project is owned by Virescent Infrastructure Investment Manager Pvt Ltd. and was developed by Globus Steel and Power Pvt Ltd. The project came online in 2016. Empower your strategies with our MPPMCL Focal Energy Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abobotulinumtoxina in Migraine
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abobotulinumtoxina in Migraine report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abobotulinumtoxina in Migraine Drug Details: Abobotulinumtoxin A (Dysport, Botulinum Toxin Type A, Azzalure)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BHV-7000 in Generalized Seizures
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BHV-7000 in Generalized Seizures report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BHV-7000 in Generalized Seizures Drug Details: BHV-7000 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Valproic Acid in Partial Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Valproic Acid in Partial Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Valproic Acid in Partial Seizure Drug Details: Valproic acid is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Epileptic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Epileptic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Epileptic Encephalopathy Drug Details: LP-352 (AN-352) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GWP-42006 in Partial Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GWP-42006 in Partial Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GWP-42006 in Partial Seizure Drug Details: GWP-42006 (CBDV, cannabidivarin) is under development...